Menu
  • Home
  • About Us
    • About 340B Report
    • Who We Are
    • Testimonials
    • Work With 340B Report
    • Contact
  • Subscribe Now
  • Document Center
  • Expert Directory
  • Events Calendar
  • Industry Insights
  • Sponsor/Advertise
  • Sign in
  • Subscriber FAQ
340B Report

340B Report

Category: Regulatory

HRSA Releases Details and FAQs About New 340B Dispute Resolution System

In Federal, RegulatoryJanuary 12, 2021 Tom Mirga
The U.S. Health Resources and Services Administration (HRSA) Tuesday afternoon posted a new webpage describing the steps health care providers and drug manufacturers must follow to invoke the 340B program’s new administrative dispute resolution (ADR) process. It simultaneously posted 11 …
Read More »

340B Providers Blindsided by Bausch Health’s Decision to Drop AmerisourceBergen as Distributor

In Federal, Other Industry, Pharma Industry, RegulatoryJanuary 12, 2021 Tom Mirga
Drug manufacturer Bausch Health blindsided 340B covered entities on New Year’s Eve, announcing that starting the very next day, Jan. 1, more than 200 of its branded products and future branded products would no longer be available through distributor AmerisourceBergen …
Read More »

Senate Democratic Chairs-in-Waiting Waste No Time Going to Bat for 340B Providers

In Federal, Legislative, Pharma Industry, RegulatoryJanuary 12, 2021 Tom Mirga
The incoming Democratic chairs of two key U.S. Senate committees want the federal agency in charge of the 340B program “to take immediate action to clarify that implementation of a rebate model by [drug] manufacturers would violate a material condition …
Read More »

Nevada Ryan White Clinics Furious About State ADAP’s 340B Policy Change

In Regulatory, StateJanuary 12, 2021 Tom Mirga

Nevada Ryan White CARES Act grantees enrolled in 340B are strongly protesting a state AIDS Drug Assistance Program (ADAP) policy change that the clinics say will deprive them of 340B savings on drugs that pay for housing, transportation, and

…
Read More »

BREAKING: HHS’s Top Lawyer Says Pharma’s 340B Contract Pharmacy Actions Are at Odds with the Law

In Breaking, Federal, Judicial, RegulatoryDecember 31, 2020 Tom Mirga

The U.S. Health and Human Services Department’s (HHS) top lawyer today rejected drug manufacturers’ legal arguments for either ending or imposing conditions on 340B pricing on covered outpatient drugs shipped to contract pharmacies.

 

Please Login

…
Read More »

BREAKING: HHS Says 340B Discounts Apply to Contract Pharmacies

In Breaking, Federal, Judicial, RegulatoryDecember 30, 2020 Tom Mirga
…
Read More »

HRSA Releases 340B Insulin Final Rule Over Health Centers’ Strong Objections

In Federal, Regulatory, Trade AssociationDecember 22, 2020 Tom Mirga
…
Read More »

White House Clears 340B Insulin Final Rule for Publication

In Federal, RegulatoryDecember 18, 2020 Tom Mirga

 


340B Report will be available exclusively to paying subscribers starting Jan. 1. Don’t miss out on our Early Bird 20% discount (available until Dec. 31, 2020). We’ve kept 340B Report free for

…
Read More »

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

In Federal, Other Industry, Pharma Industry, RegulatoryDecember 17, 2020 Tom Mirga

Drug manufacturer vendor Kalderos says it expects several companies to begin using its 340B Pay platform during the next three months.

 

Kalderos Expects its 340B Rebate Model

…
Read More »

The New York Times, Often a Public Policy Shaper, Runs Article on 340B Pricing Denials

In Federal, Other Industry, Pharma Industry, RegulatoryDecember 16, 2020 Tom Mirga
…
Read More »

Posts navigation

1 2 3 4 … 14

Site Sidebar

Categories

  • Breaking
  • Federal
  • Judicial
  • Legislative
  • Non-Governmental
  • Other Industry
  • Pharma Industry
  • Regulatory
  • Research/Reports
  • State
  • Trade Association
  • Uncategorized

Recent Posts

  • Eight Days Left Before Subscription Prices Go Up By 20 Percent
  • BREAKING: PhRMA Asks Court to Strike Down 340B Dispute Resolution Rule and Manufacturer Audit Guidelines
  • Nine Days Left To Take Advantage of Significant Subscription Discounts
  • Biden Administration Withdraws Azar’s Notice of Appointments to 340B Dispute Resolution Board
  • Biden Team Freezes 340B Insulin Rule, to Health Centers’ Relief

Site Footer

Terms of Use Privacy Policy